Flyrcado™ flurpiridaz F 18 injection
Flyrcado helps uncover coronary artery disease that other modalities and older tracers often miss, delivering exceptional image clarity and diagnostic confidence. Its unit‑dose distribution model expands access to cardiac PET, while the long half-life makes exercise stress truly feasible for the first time in cardiac PET.